Editor's Correspondence |

Recommendations for Diagnosis, Evaluation, and Monitoring of Patients With Gaucher Disease

Deborah Elstein, PhD; Ayala Abrahamov, MD; Irith Hadas-Halpern, MD; Ari Zimran, MD
Arch Intern Med. 1999;159(11):1254. doi:.
Text Size: A A A
Published online


In a recent issue of the ARCHIVES, Charrow et al,1 as US regional coordinators for the International Collaborative Gaucher Group (ICGG) registry, present their recommendations for diagnosis, evaluation, and monitoring of patients with Gaucher disease. As the largest referral clinic for Gaucher disease outside the United States, our recommendations regarding monitoring differ to some extent from those enumerated in the above-mentioned article. We feel that the recommendation to use magnetic resonance imaging (MRI) or computed tomography (CT) for repeated evaluation of visceral involvement is probably unnecessary outside the constraints of a clinical trial. Ultrasound is highly accurate, universally available, inexpensive, involves no exposure to radiation, and the measurements can be easily converted for comparison to MRI2 and CT.3 Similarly, the recommendations for technetium Tc 99m sulfur colloid nuclear scanning and quantitative chemical shift MRI for routine bone assessment are problematic, not being universally available, and not clearly adding to the clinical appraisal of the patient. For skeletal involvement, we prefer dual energy x-ray absorptiometry in all adult patients as a measure of bone mass density at annual intervals. Plain radiography is performed at baseline and then only again as dictated by clinical events, in that 24 to 42 months are needed to evince radiographic documentation of improvement owing to enzyme treatment.4,5

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles